TMDX TransMedics Group Earnings and EPS analysis

Relative Growth: Rel. Growth: 81

Relative Strength: Rel. Strength: 32

Relative Valuation: Rel. Valuation: 63

Relative Profitability: Rel. Profitability: 85

EPS in 2026 (TTM): $4.44

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the current EPS (TTM) is $4.44. TransMedics Group's EPS for 2025 came in at $5.6, marking an increase from $1.07 in 2024. For the quarterly period ending on Jun 30, 2026, TMDX's EPS was $0.42.

TMDX earnings history

Historical annual and quarterly earnings per share (EPS) data for TransMedics Group

EPS (TTM)

$4.44

EPS Growth YoY (Quarterly)

-59.2%

EPS (Quarterly)

$0.42

EPS Growth (Quarterly)

100%

TransMedics Group had an annual EPS of $5.6, marking an increase of 423.4% from $1.07 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was $0.42, marking a 59.2% decrease from the same quarter last year. TMDX's TTM EPS stands at $4.44 as of June 2026. TransMedics Group's EPS for 2024 stood at $1.07, a 239% increase from 2023.

TMDX EPS vs price chart

TMDX EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-59.2%

EPS growth YoY

423.4%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

TransMedics Group has recorded a decrease in EPS of 59.2% over the last 12 months (YoY, quarterly).

TMDX Earnings Waterfall

Breakdown of revenue, profit and net income for TransMedics Group

TMDX Earnings vs Peers

What are the earnings of TMDX compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
TMDX TransMedics Group Inc	19.59	423.4%	N/A	N/A
OBIO Orchestra BioMed Holdings Inc	N/A	33.1%	N/A	N/A
OM Outset Medical Inc	N/A	85.5%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.